These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31107951)

  • 1. Humoral Immune Correlates for Prevention of Postnatal Cytomegalovirus Acquisition.
    Saccoccio FM; Jenks JA; Itell HL; Li SH; Berry M; Pollara J; Casper C; Gantt S; Permar SR
    J Infect Dis; 2019 Jul; 220(5):772-780. PubMed ID: 31107951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus IgG Level and Avidity in Breastfeeding Infants of HIV-Infected Mothers in Malawi.
    Kourtis AP; Wiener J; Chang TS; Dollard SC; Amin MM; Ellington S; Kayira D; van der Horst C; Jamieson DJ
    Clin Vaccine Immunol; 2015 Dec; 22(12):1222-6. PubMed ID: 26424831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant Antiviral CD8
    Pardieck IN; van Duikeren S; Veerkamp DMB; Brasem DJ; Redeker A; van Bergen J; Han W; Ossendorp F; Zondag G; Arens R
    Front Immunol; 2022; 13():680559. PubMed ID: 35154089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice.
    Chiuppesi F; Nguyen J; Park S; Contreras H; Kha M; Meng Z; Kaltcheva T; Iniguez A; Martinez J; La Rosa C; Wussow F; Diamond DJ
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal cytomegalovirus-specific immune responses and symptomatic postnatal cytomegalovirus transmission in very low-birth-weight preterm infants.
    Ehlinger EP; Webster EM; Kang HH; Cangialose A; Simmons AC; Barbas KH; Burchett SK; Gregory ML; Puopolo KM; Permar SR
    J Infect Dis; 2011 Dec; 204(11):1672-82. PubMed ID: 21984738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Human Immunodeficiency Virus and Cytomegalovirus Infection on Infant Responses to Vaccines: A Review.
    Falconer O; Newell ML; Jones CE
    Front Immunol; 2018; 9():328. PubMed ID: 29552009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Replication-Defective Human Cytomegalovirus Vaccine Elicits Humoral Immune Responses Analogous to Those with Natural Infection.
    Liu Y; Freed DC; Li L; Tang A; Li F; Murray EM; Adler SP; McVoy MA; Rupp RE; Barrett D; Ye X; Zhang N; Beck K; Culp T; Das R; Song L; Vora K; Zhu H; Wang D; Espeseth AS; An Z; Musey L; Fu TM
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity.
    Boppana SB; Rivera LB; Fowler KB; Mach M; Britt WJ
    N Engl J Med; 2001 May; 344(18):1366-71. PubMed ID: 11333993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity.
    Deere JD; Chang WLW; Villalobos A; Schmidt KA; Deshpande A; Castillo LD; Fike J; Walter MR; Barry PA; Hartigan-O'Connor DJ
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):13036-13041. PubMed ID: 31189602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality.
    Swanson EC; Gillis P; Hernandez-Alvarado N; Fernández-Alarcón C; Schmit M; Zabeli JC; Wussow F; Diamond DJ; Schleiss MR
    Vaccine; 2015 Jul; 33(32):4013-8. PubMed ID: 26079615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal and neonatal anti-cytomegalovirus IgG level and risk of postnatal cytomegalovirus transmission in preterm infants.
    Nijman J; van Loon AM; Krediet TG; Verboon-Maciolek MA
    J Med Virol; 2013 Apr; 85(4):689-95. PubMed ID: 23296599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of cytomegalovirus infection during clinical trials of glycoprotein B vaccine.
    Zhang C; Pass RF
    Vaccine; 2004 Dec; 23(4):507-10. PubMed ID: 15530699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.
    Nelson CS; Huffman T; Jenks JA; Cisneros de la Rosa E; Xie G; Vandergrift N; Pass RF; Pollara J; Permar SR
    Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6267-6272. PubMed ID: 29712861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus (CMV) glycoprotein H-based serological analysis in Japanese healthy pregnant women, and in neonates with congenital CMV infection and their mothers.
    Ikuta K; Minematsu T; Inoue N; Kubo T; Asano K; Ishibashi K; Imamura T; Nakai H; Yoshikawa T; Moriuchi H; Fujiwara S; Koyano S; Suzutani T
    J Clin Virol; 2013 Oct; 58(2):474-8. PubMed ID: 23916379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic intravenous immunoglobulin injections to mothers with primary cytomegalovirus infection.
    Tanimura K; Tairaku S; Deguchi M; Sonoyama A; Morizane M; Ebina Y; Morioka I; Yamada H
    Kobe J Med Sci; 2014 Jul; 60(2):E25-9. PubMed ID: 25339256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates.
    Mussi-Pinhata MM; Pinto PC; Yamamoto AY; Berencsi K; de Souza CB; Andrea M; Duarte G; Jorge SM
    J Med Virol; 2003 Feb; 69(2):232-9. PubMed ID: 12683413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model.
    Schleiss MR; Choi KY; Anderson J; Mash JG; Wettendorff M; Mossman S; Van Damme M
    Vaccine; 2014 May; 32(23):2756-62. PubMed ID: 23867012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine.
    Schleiss MR; Bourne N; Stroup G; Bravo FJ; Jensen NJ; Bernstein DI
    J Infect Dis; 2004 Apr; 189(8):1374-81. PubMed ID: 15073673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal Antibody Responses and Nonprimary Congenital Cytomegalovirus Infection of HIV-1-Exposed Infants.
    Bialas KM; Westreich D; Cisneros de la Rosa E; Nelson CS; Kauvar LM; Fu TM; Permar SR
    J Infect Dis; 2016 Dec; 214(12):1916-1923. PubMed ID: 27923951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.